The Pregravid Vascular Risk Factor Profile of Low-Risk Women Who Develop Pregnancy Outcomes That Predict Future Cardiovascular Disease

• Main Authors: Roslyn Mainland (Author), Shi Wu Wen (Author), Hongzhuan Tan (Author), Shujin Zhou (Author), Chang Ye (Author), Minxue Shen (Author), Graeme N. Smith (Author), Mark C. Walker (Author), Ravi Retnakaran (Author)
• Format: Book
• Published: Mary Ann Liebert, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1089/WHR.2021.0006; 2688-4844
• Keywords: cardiovascular risk factors; metabolic syndrome; preconception; prepregnancy; Gynecology and obstetrics; RG1-991; Public aspects of medicine; RA1-1270
• Source: Women's Health Reports, Vol 2, Iss 1, Pp 62-70 (2021)

Background: Women with a history of certain adverse outcomes in pregnancy (preterm birth, delivery of a small-for-gestational age [SGA] infant, preeclampsia, and gestational diabetes mellitus [GDM]) have an elevated lifetime prevalence of metabolic syndrome (MetS) and cardiovascular disease, compared with their peers. However, it is not known if MetS precedes the index pregnancy in young, nulliparous women who experience these antepartum outcomes. Thus, we sought to evaluate the relationship between pregravid cardiovascular risk factor profile and these pregnancy outcomes in low-risk women. Methods: In this prospective preconception cohort study, 1183 newly married women underwent systematic assessment of cardiovascular risk factors (anthropometry, blood pressure, lipids, glucose) at median 24.7 weeks before pregnancy, whereupon they were followed for the outcomes of preterm birth, SGA delivery, preeclampsia, and GDM. Results: Women who had pregravid MetS (harmonized definition) (n?=?49) were more likely to have a Caesarean delivery than their peers (61.4% vs. 38.6%, p?=?0.003). However, they did not have a higher incidence of preterm delivery, SGA, preeclampsia, or GDM. Similarly, women who had at least one of these adverse pregnancy outcomes (n?=?141) did not have a higher prevalence of MetS or any of its component disorders before pregnancy. Indeed, before pregnancy, there were no significant differences between these women and their peers in waist circumference, body mass index, blood pressure, fasting glucose, triglycerides, low-density-lipoprotein, or high-density-lipoprotein cholesterol. Conclusions: The adverse cardiovascular risk factor profile that is seen in women with a history of preterm birth, SGA, preeclampsia, or GDM does not necessarily manifest before their pregnancy.